Swedish pharmaceutical company Meda
has signed a Skr4.15bn (Eu444m) syndicated loan. The multicurrency deal comprises a Skr2.15bn three year term loan and a Skr2bn one year revolver with two one year extension options.
Danske Bank, SEB, Svenska Handelsbanken and Swedbank each committed Skr500m to the revolver, which was unsyndicated.
Please take a trial or subscribe to access this content.
Contact our subscriptions team to discuss your access: firstname.lastname@example.org
To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: email@example.com or find out more online here.